AMETEK (NYSE:AME) Stock Price Expected to Rise, BNP Paribas Exane Analyst Says

AMETEK (NYSE:AME) had its price target lifted by research analysts at BNP Paribas Exane from $280.00 to $290.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an “outperform” rating on the technology company’s stock. BNP Paribas Exane’s target price suggests a potential upside of 19.84% from the stock’s previous close.

Several other analysts have also weighed in on the company. Citigroup raised their price objective on AMETEK from $257.00 to $261.00 and gave the company a “neutral” rating in a research note on Wednesday, August 5th. Morgan Stanley increased their target price on shares of AMETEK from $235.00 to $245.00 and gave the stock an “equal weight” rating in a report on Friday, July 10th. KeyCorp raised their price target on shares of AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a research note on Wednesday, August 5th. DA Davidson lifted their price target on shares of AMETEK from $265.00 to $285.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, Robert W. Baird set a $275.00 price objective on shares of AMETEK in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $266.69.

AMETEK Price Performance

Shares of NYSE:AME traded up $7.75 during midday trading on Friday, hitting $241.99. The stock had a trading volume of 403,897 shares, compared to its average volume of 1,284,930. The company’s 50-day moving average price is $241.27 and its 200-day moving average price is $232.61. AMETEK has a fifty-two week low of $179.24 and a fifty-two week high of $261.16. The company has a quick ratio of 0.76, a current ratio of 1.21 and a debt-to-equity ratio of 0.09. The company has a market capitalization of $55.46 billion, a P/E ratio of 35.37, a price-to-earnings-growth ratio of 3.02 and a beta of 0.99.

AMETEK (NYSE:AME) last posted its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.10. AMETEK had a net margin of 20.04% and a return on equity of 16.93%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $1.95 billion. During the same quarter last year, the business posted $1.78 EPS. The firm’s revenue for the quarter was up 15.0% on a year-over-year basis. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. As a group, equities research analysts predict that AMETEK will post 8.32 EPS for the current fiscal year.

Insider Buying and Selling

In other AMETEK news, insider David Hermance sold 6,608 shares of AMETEK stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $254.00, for a total value of $1,678,432.00. Following the completion of the sale, the insider directly owned 42,509 shares in the company, valued at approximately $10,797,286. The trade was a 13.45% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.54% of the stock is owned by corporate insiders.

Institutional Trading of AMETEK

Several large investors have recently modified their holdings of AME. Florida Financial Advisors LLC boosted its stake in AMETEK by 2.2% during the 4th quarter. Florida Financial Advisors LLC now owns 1,974 shares of the technology company’s stock valued at $406,000 after acquiring an additional 43 shares during the last quarter. Root Financial Partners LLC increased its position in shares of AMETEK by 18.3% in the 1st quarter. Root Financial Partners LLC now owns 323 shares of the technology company’s stock worth $69,000 after purchasing an additional 50 shares during the last quarter. ICW Investment Advisors LLC increased its position in shares of AMETEK by 0.7% in the 4th quarter. ICW Investment Advisors LLC now owns 7,831 shares of the technology company’s stock worth $1,608,000 after purchasing an additional 51 shares during the last quarter. FUKOKU MUTUAL LIFE INSURANCE Co raised its stake in shares of AMETEK by 4.6% in the 4th quarter. FUKOKU MUTUAL LIFE INSURANCE Co now owns 1,158 shares of the technology company’s stock valued at $238,000 after purchasing an additional 51 shares in the last quarter. Finally, Sivia Capital Partners LLC lifted its position in shares of AMETEK by 2.5% during the fourth quarter. Sivia Capital Partners LLC now owns 2,070 shares of the technology company’s stock worth $425,000 after purchasing an additional 51 shares during the last quarter. Institutional investors and hedge funds own 87.43% of the company’s stock.

About AMETEK

AMETEK, Inc (NYSE: AME) is a diversified manufacturer of industrial technology products and solutions. The company develops equipment used to monitor, measure, test, control and analyze processes across a range of industrial and commercial applications.

AMETEK operates through two primary business groups: Electronic Instruments, which provides analytical, monitoring, testing and measurement equipment; and Electromechanical, which supplies automation systems, motors, power systems, aerospace and defense products, engineered materials and other specialized components.